NPI Lens

Diana Escolar, MD

NPI 1215014543ActiveIndividual· Psychiatry & Neurology, Neurology· Washington, DC

Psychiatry & Neurology, Neurology (MD) in Washington, District of Columbia, licensed in DC, with an NPI issued in November 2006. Acadia Pharmaceuticals Inc reported $49,500 in payments in 2025, mostly consulting fees.

Overview

NPI1215014543
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedNov 1, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Psychiatry & Neurology, Neurology Primary2084N0400XMD20110DC

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$49,500 · 3 payments from 1 company
  • 2024$34,155 · 3 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Acadia Pharmaceuticals Inc$49,5003

What the 2025 payments were for

  • Consulting Fee$36,000 · 1 payment
  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$13,500 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other neurologists in Washington

All 147 neurologists in Washington · All neurologists in District of Columbia